Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01152593

Enrollment

400

Registered

2010-06-29

Start date

2010-07-31

Completion date

2014-12-31

Last updated

2010-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Wound Infection, Cesarean Section, Staphylococcus Aureus

Brief summary

The investigators believe that irradication of nose colonization of staphyloccocus aureus will reduce the incidence of surgical site infections after cesarean section.

Interventions

DRUGMupirocin

Intranasal cream given to patient after confirmation of colonization

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Inclusion criteria

* Women assigned to undergo cesarean section

Exclusion criteria

* All others

Design outcomes

Primary

Measure	Time frame
Reduction of the incidence of surgical site infections after cesarean section	Four years

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026